Rachel Christian
About Rachel Christian
Rachel Christian is the Principal Clinical Liaison for Neuromodulation at Boston Scientific, with a diverse background in nursing and pharmaceutical sales.
Company
Rachel Christian currently holds the position of Principal Clinical Liaison - Neuromodulation at Boston Scientific, located in Estero, Florida, United States. She has been with the company since 2021, where she collaborates with a team of skilled clinicians on various clinical research projects.
Title
Rachel Christian is the Principal Clinical Liaison - Neuromodulation at Boston Scientific. In this role, she facilitates collaboration among clinicians for clinical research, focusing on neuromodulation.
Education and Expertise
Rachel Christian earned her Master's Degree in Acute Care Nurse Practitioner from Vanderbilt University School of Nursing (2008-2010) and her Bachelor's Degree in Biology & Nursing from the University of Missouri-Columbia (1997-2003). She has extensive expertise in evidence-based medicine, intraoperative care, ambulatory care, and inpatient care.
Background
Rachel Christian's career began as a Staff Nurse in the United States Air Force, where she served as Captain and received two medals for outstanding achievement and meritorious service (2004-2008). She then worked as an Oncology & Infusional Clinic Nurse at Tennessee Oncology (2008-2010) and a Surgical Oncology Acute Care Nurse Practitioner at HCA in Nashville, TN (2010-2015). Her experience includes roles as The Breast Center Nurse Practitioner at the University of Colorado School of Medicine (2015-2017), Neurosurgery Nurse Practitioner at University of Louisville Physicians (2017-2019), and Oncology Specialty Sales Representative at Merck (2019-2021).
Achievements
Rachel Christian received two commendations for outstanding achievement and meritorious service during her time as an Active Duty Air Force Officer. Her career highlights include facilitating clinical collaborations and transitioning from a nurse practitioner in neurosurgery and oncology to a specialty sales representative in the pharmaceutical industry before assuming her current role in neuromodulation.